# Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients

> **NCT00664703** · PHASE2 · COMPLETED · sponsor: **Yaupon Therapeutics** · enrollment: 13 (actual)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DRUG:** Lobeline sulfate
- **DRUG:** Methylphenidate HCl
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00664703
- **Lead sponsor:** Yaupon Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2013-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00664703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00664703, "Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00664703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*